Tenaya Therapeutics (TNYA) Retained Earnings (2020 - 2026)
Tenaya Therapeutics' quarterly Retained Earnings came in at -$624.3 million in Q1 2026, down 6242900.0% year-on-year from N/an in Q1 2025, and down 3.19% quarter-over-quarter from -$605.0 million in Q4 2025.
Tenaya Therapeutics has reported Retained Earnings for 7 years, with the latest figure at -$624.3 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 6242900.0% year-over-year to -$624.3 million; the trailing twelve-month figure through Mar 2026 stood at -$624.3 million (down 6242900.0% YoY), and the FY2025 full-year result was -$605.0 million, down 17.61% from the prior year.
- Retained Earnings for Q1 2026 stood at -$624.3 million, down from -$605.0 million in the prior quarter.
- The five-year high for Retained Earnings was -$10000.0 in Q1 2025, with the low at -$624.3 million in Q1 2026.
- Average Retained Earnings over 5 years is -$341.3 million, with a median of -$403.3 million recorded in 2023.
- Year-over-year, Retained Earnings soared 100.0% in 2025 and tumbled 6242900.0% in 2026.
- Tracing TNYA's Retained Earnings over 5 years: stood at -$279.2 million in 2022, then sank by 44.44% to -$403.3 million in 2023, then retreated by 27.56% to -$514.4 million in 2024, then decreased by 17.61% to -$605.0 million in 2025, then fell by 3.19% to -$624.3 million in 2026.
- The last three Retained Earnings figures came in at -$624.3 million (Q1 2026), -$605.0 million (Q4 2025), and -$584.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Tenaya Therapeutics | 193.57 Mn | 193.57 Mn | - | -624.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -624.30 Mn |
| Dec 31, 2025 | -605.01 Mn |
| Sep 30, 2025 | -584.83 Mn |
| Jun 30, 2025 | -564.56 Mn |
| Mar 31, 2025 | -10,000.00 |
| Dec 31, 2024 | -514.41 Mn |
| Sep 30, 2024 | -490.60 Mn |
| Jun 30, 2024 | -464.90 Mn |
| Mar 31, 2024 | -435.50 Mn |
| Dec 31, 2023 | -403.28 Mn |
| Sep 30, 2023 | -373.30 Mn |
| Jun 30, 2023 | -333,000.00 |
| Mar 31, 2023 | -120,000.00 |
| Dec 31, 2022 | -279.20 Mn |
| Sep 30, 2022 | -245.68 Mn |
| Jun 30, 2022 | -214.99 Mn |
| Mar 31, 2022 | -631,000.00 |
| Dec 31, 2021 | -155.53 Mn |
| Sep 30, 2021 | -23,000.00 |
| Jun 30, 2021 | -111.12 Mn |
| Dec 31, 2020 | -82.81 Mn |